Final results of the PETACC-1 trial of bolus 5-FU/LV vs raltitrexed: An unsuccessful story? by Popov, I, Wils, J, Carrato, A, Sobrero, A, Vincent, M, Kerr, D, Labianca, R, Pignatti, F, Praet, M, Nordlinger, B

Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts by Camps Herrero C, Antón Torres A, Cruz-Hernández JJ, Carrato A, Constenla M, Díaz-Rubio E, Feyjoo Saus M, Garcia-Foncillas J, Gascón P, Guillem V

Get full text

Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). by Popov, I, Carrato, A, Sobrero, A, Vincent, M, Kerr, D, Labianca, R, Raffaele Bianco, A, El-Serafi, M, Bedenne, L, Paillot, B, Mini, E, Sanches, E, Welch, J, Collette, L, Praet, M, Wils, J